| Literature DB >> 29132563 |
Jennifer M Racz1, Amy C Degnim2.
Abstract
Atypical ductal hyperplasia (ADH) is a proliferative, nonobligate precursor breast lesion and a marker of increased risk for breast carcinoma. Surgical excision remains the standard recommendation following a core needle biopsy result consistent with ADH. Recent research suggests that women with no mass lesion or discordance, removal of greater than or equal to 90% of calcifications at the time of core needle biopsy, involvement of less than or equal to 2 terminal duct lobular units, and absence of cytologic atypia or necrosis are likely to have a less than 5% chance of a missed cancer.Entities:
Keywords: Atypical ductal hyperplasia; Core needle biopsy; Epithelial proliferative lesion; Surgical excision
Mesh:
Year: 2018 PMID: 29132563 DOI: 10.1016/j.soc.2017.07.011
Source DB: PubMed Journal: Surg Oncol Clin N Am ISSN: 1055-3207 Impact factor: 3.495